Literature DB >> 16974205

Panic disorder, treatment with selective serotonin reuptake inhibitors, and cholesterol levels.

Andrés Herrán, Maria L Ramírez, Maria Carrera, Maria T García-Unzueta, Deirdre Sierra-Biddle, Beatriz Rodríguez-Cabo, Ana Ayestarán, Fernando Hoyuela, Jose L Vázquez-Barquero.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16974205     DOI: 10.1097/01.jcp.0000237941.56107.b7

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  6 in total

1.  The association between panic disorder and coronary artery disease among primary care patients presenting with chest pain: an updated literature review.

Authors:  David A Katerndahl
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

2.  The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients.

Authors:  Murat Kesim; Ahmet Tiryaki; Mine Kadioglu; Efnan Muci; Nuri Ihsan Kalyoncu; Ersin Yaris
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

Review 3.  Cardiometabolic effects of psychotropic medications.

Authors:  Oluchi Abosi; Sneha Lopes; Samantha Schmitz; Jess G Fiedorowicz
Journal:  Horm Mol Biol Clin Investig       Date:  2018-01-10

4.  Metabolic Abnormalities Related to Treatment With Selective Serotonin Reuptake Inhibitors in Patients With Schizophrenia or Bipolar Disorder.

Authors:  Katrine Kveli Fjukstad; Anne Engum; Stian Lydersen; Ingrid Dieset; Nils Eiel Steen; Ole A Andreassen; Olav Spigset
Journal:  J Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.153

5.  Effects of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, on Perceived Stress and Cognitive Function Among Patients With Late-Life Depression: A Randomized, Double-Blind, Sertraline- and Placebo-Controlled Trial.

Authors:  Chieh-Hsin Lin; Shi-Heng Wang; Hsien-Yuan Lane
Journal:  Int J Neuropsychopharmacol       Date:  2022-08-04       Impact factor: 5.678

Review 6.  Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: A controversial but promising approach.

Authors:  Alfredo Bellon; Kieuhanh Nguyen
Journal:  World J Psychiatry       Date:  2021-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.